Why the study?
Choosing optimal revascularization strategies for obstructive CAD remains challenging, as randomized trials provide population-level insights but leave gaps in personalized decision-making.
Does an offline reinforcement learning clinical decision support tool (RL4CAD) improve expected rewards based on composite major cardiovascular events compared to physician-based decision making in patients with angiography-confirmed obstructive CAD?
Does an offline reinforcement learning clinical decision support tool (RL4CAD) improve expected rewards based on composite major cardiovascular events compared to physician-based decision making in patients with angiography-confirmed obstructive CAD?
Answers are grounded in this paper and cite their sources.
An offline reinforcement learning model (RL4CAD) for personalized revascularization strategies in obstructive CAD outperformed standard physician decision-making in simulated expected rewards, highlighting the potential of AI-driven clinical decision support.
Choosing optimal revascularization strategies for patients with obstructive coronary artery disease (CAD) remains a clinical challenge. While randomized controlled trials offer population-level insights, gaps remain regarding personalized decision-making for individual patients. We applied off-policy reinforcement learning (RL) to a composite data model from 41,328 unique patients with angiography-confirmed obstructive CAD. In an offline setting, we estimated optimal treatment policies and evaluated these policies using weighted importance sampling. Our findings indicate that RL-guided therapy decisions outperformed physician-based decision making, with RL policies achieving up to 32% improvement in expected rewards based on composite major cardiovascular events outcomes. Additionally, we introduced methods to ensure that RL CAD treatment policies remain compatible with locally achievable clinical practice models, presenting an interpretable RL policy with a limited number of states. Overall, this novel RL-based clinical decision support tool, RL4CAD, demonstrates potential to optimize care in patients with obstructive CAD referred for invasive coronary angiography.
No takes yet. Share an insight, caveat, or question.
Ghasemi et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: